XTalks

MAY 20, 2022

Depending on the type of field or company, you can pursue clinical scientist jobs with a major in biology, medicine, medical technology, chemistry, immunology and other related life science and pre-medical degrees. Below is a brief preview from the National Health Services’ list of healthcare science fields: Vascular Science.

Scientist 105

Scientist Life Science Clinical Research Doctors 105

The Pharma Data

NOVEMBER 15, 2020

Our rigorous target selection process, translational screening cascade, and smart medicinal chemistry have been essential to bring this project to this stage. Lead Pharma is a pharmaceutical company focusing on the discovery and development of innovative medicines for the treatment of immune diseases and cancer.

Licensing 52

Licensing Licensing Development Research 52

Drug Discovery World

JULY 11, 2023

Tim Lowery , President, JSR Life Sciences, asks whether artificial intelligence can do for life sciences what it has done in other sectors and whether these tools can keep up with the complexities of human biology. So, where do we go from here to realise their potential in life sciences?

Big Data 40

Big Data Development Life Science Drugs 40

Drug Discovery World

OCTOBER 20, 2023

The acquisition of Olink underscores the profound impact that proteomics is having as our customers continue to advance life science research and precision medicine,” said Marc Casper, Chairman, President and Chief Executive Officer of Thermo Fisher.

Drugs 52

Drugs Antibody DNA Gene Therapy 52

pharmaphorum

MAY 27, 2022

This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials. data processing systems that support bioinformatics modelling) and digital record systems (e.g. You can read part one of this article here. About the interviewees.

Clinical Trials 78

Clinical Trials Clinical Trials Trials Packaging 78

XTalks

SEPTEMBER 28, 2020

The leading global life science company is set to introduce Resolution Bio’s ctDx Lung assay , a non-invasive liquid biopsy test for patients with non-small cell lung cancer (NSCLC). The liquid biopsy will therefore help personalize medicines for patients based on the molecular features of their disease.

Gene 105

Gene DNA Life Science Genotype 105

Scienmag

DECEMBER 22, 2020

Under atomic force microscopy (AFM), e.g., their surface can be rapidly scanned, and functional motions monitored, which is of great importance for applications in all fields of Life science. The analysis and interpretation of experimental results remains however challenging because the resolution of […].

Life Science 52

Life Science Protein Bioinformatics Engineer 52

Drug Discovery World

DECEMBER 26, 2023

Donidalorsen is an investigational ligand-conjugated antisense (LICA) medicine designed to target the prekallikrein, or PKK, pathway. We are excited to collaborate with Otsuka given their proven results in bringing rare disease medicines to patients in Europe,” said Brett Monia, Ionis Chief Executive Officer.

Drugs 52

Drugs Development Medicine Bioinformatics 52

Drug Discovery World

OCTOBER 26, 2023

To enable Evotec’s precision medicine approach, we have been building technology platforms that allow PanOmics or multi-omics data generation at an industrialised scale. All statistical algorithms in PanHunter are peer-reviewed, ensuring that the results are trustworthy and reproducible by users with all levels of bioinformatic skills.

Drugs 52

Drugs Protein Genome Genomics 52

Drug Discovery World

FEBRUARY 6, 2023

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care.

Big Data 52

Big Data RNA Bioinformatics Vaccination 52

XTalks

DECEMBER 13, 2023

These efforts encompass programs related to the shingles vaccine, Tdap vaccine and plague vaccine, reinforcing Dynavax’s commitment to advancing the field of vaccines and medicine. The enduring success of Aravive can be attributed to its ongoing investment in R&D and the commercialization of innovative new medicines.

Genetics 111

Genetics Vaccination Vaccine DNA 111

The Pharma Data

MARCH 2, 2021

Making new and better medicines for humans and animals is at the heart of what we do. billion euros in R&D drives innovation, enabling the next generation of medicines that save lives and improve quality of life. Financial terms of the new agreement are not disclosed. About Boehringer Ingelheim.

In-Vivo 52

In-Vivo Contract Manufacturing Bioinformatics Clinical Development 52

Drug Discovery World

APRIL 21, 2023

SLAS Europe 2023 will take place 22-26 May in Brussels, Belgium, where attendees will embrace the theme Science Set in Motion. DDW’s Multimedia Editor Megan Thomas explores what to expect from the event. The Brussels Expo welcomes more than 100 exhibitors, including many companies whose work makes these tracks possible.

Doctors 52

Doctors Doctor Genetics In-Vitro 52

Drug Discovery World

NOVEMBER 13, 2023

Novel/alternative ML-enabled screening technologies for higher POS Following chairperson’s remarks from M Frank Erasmus, PhD, Head, Bioinformatics, Specifica, there will be four presentations and a panel discussion. It is called, ‘An unexpected future for immune oncology therapies?’

Protein 59

Protein Antibody Engineer Scientist 59

XTalks

NOVEMBER 7, 2022

The leaders in this space now are Foundation Medicine and Guardant360, which have a large number of FDA-approved companion diagnostic assays for different indications,” said Dr. Bahassi. FoundationOne ® Liquid CDx (Foundation Medicine; end-to-end commercial provider). Optimal methods for bioinformatic analysis are still needed.

Clinical Trials 98

Clinical Trials Clinical Trials Trials FDA Approval 98

Drug Discovery World

NOVEMBER 9, 2023

Benjamin Hackel, PhD, Professor, Chemical Engineering & Materials Science, University of Minnesota, on: ‘Engineering hyperstable synthetic miniproteins as developable ligands’. James Cooke, PhD, Associate Director, Bicycle Therapeutics, on: ‘Engineering bicyclic peptides for precision targeted medicine’. Crystal Richardson, Ph.D,

Engineer 52

Engineer Antibody Protein In-Vivo 52